M. Sharpe

发表

Suicidal thoughts in patients with cancer and comorbid major depression: findings from a depression screening program.

Janeane L. Walker, N. Magill, D. Rosenstein, 2021, Journal of the Academy of Consultation-Liaison Psychiatry.

Depression after stroke and lesion location: a systematic review

Michael Sharpe, Stephen M Lawrie, Allan House, 2000, The Lancet.

What should we call pseudoseizures? The patient’s perspective

C. Warlow, M. Sharpe, A. Carson, 2003, Seizure.

Disability, distress and unemployment in neurology outpatients with symptoms ‘unexplained by organic disease’

C. Warlow, K. Matthews, R. Duncan, 2011, Journal of Neurology, Neurosurgery & Psychiatry.

The science of clinical practice: disease diagnosis or patient prognosis? Evidence about “what is likely to happen” should shape clinical practice

M. Leboyer, D. Altman, S. Petersen, 2015, BMC Medicine.

Enhanced care by generalists for functional somatic symptoms and disorders in primary care: Intervention Protocol

M. Frydenberg, K. Kroenke, P. Fink, 2009 .

Liaison psychiatry: Defining needs and planning services

M. Sharpe, 1995 .

Unexplained Symptoms After Terrorism and War: An Expert Consensus Statement

Michael Sharpe, Simon Wessely, Daniel J Clauw, 2003, Journal of occupational and environmental medicine.

Healthcare costs incurred by patients repeatedly referred to secondary medical care with medically unexplained symptoms: a cost of illness study.

M. Sharpe, G. Richardson, D. Weller, 2012, Journal of psychosomatic research.

Depressive Disorders in Long-Term Survivors of Stroke

P. Sandercock, A. House, C. Warlow, 1994, British Journal of Psychiatry.

Neurological disease, emotional disorder, and disability: they are related: a study of 300 consecutive new referrals to a neurology outpatient department

C. Warlow, M. Sharpe, A. Carson, 2000, Journal of neurology, neurosurgery, and psychiatry.

9 – Research methods, statistics and evidence-based practice

S. Lawrie, A. McIntosh, M. Sharpe, 2010 .

Follow up of patients presenting with fatigue to an infectious diseases clinic.

V. Seagroatt, M. Sharpe, K. Hawton, 1992, BMJ.

Is co-morbid depression adequately treated in patients repeatedly referred to specialist medical services with symptoms of a medical condition?

M. Sharpe, D. Weller, C. Burton, 2012, Journal of psychosomatic research.

Can oncology nurses treat depression? A pilot project.

A. House, P. Maguire, M. Sharpe, 2004, Journal of advanced nursing.

Management of major depression in outpatients attending a cancer centre: a preliminary evaluation of a multicomponent cancer nurse-delivered intervention

A. House, P. Maguire, M. Sharpe, 2004, British Journal of Cancer.

Diagnosing major depression in medical outpatients: acceptability of telephone interviews.

M. Sharpe, A. Cull, K. Allen, 2003, Journal of psychosomatic research.

The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2): a randomised trial to determine the effectiveness and cost-effectiveness of adding a complex intervention for major depressive disorder to usual care for cancer patients

Janeane L. Walker, J. Cassidy, M. Sharpe, 2009, Trials.

Management of depression for people with cancer (SMaRT oncology 1): a randomised trial

G. Murray, Janeane L. Walker, M. Sharpe, 2008, The Lancet.

Pain Management in Cancer Center Inpatients: A Cluster Randomized Trial to Evaluate a Systematic Integrated Approach—The Edinburgh Pain Assessment and Management Tool

G. Murray, M. Fallon, Janeane L. Walker, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pain in patients attending a specialist cancer service: prevalence and association with emotional distress.

M. Fallon, A. Kleiboer, Janeane L. Walker, 2012, Journal of pain and symptom management.

Clinical Adoption of Advanced Therapies: Challenges and Opportunities.

M. Sharpe, P. Kefalas, J. Barry, 2020, Journal of pharmaceutical sciences.

Somatoform disorders: time for a new approach in DSM-V.

K. Kroenke, L. Kirmayer, M. Sharpe, 2005, The American journal of psychiatry.

Can Neuroimaging Help Us to Understand and Classify Somatoform Disorders? A Systematic and Critical Review

P. Fletcher, M. Browning, M. Sharpe, 2011, Psychosomatic medicine.

The 12 year prognosis of unilateral functional weakness and sensory disturbance

P. Rothwell, C. Warlow, M. Sharpe, 2003, Journal of neurology, neurosurgery, and psychiatry.

Are functional motor and sensory symptoms really more frequent on the left? A systematic review

S. Lewis, C. Warlow, M. Sharpe, 2002, Journal of neurology, neurosurgery, and psychiatry.

The Prevalence of Psychiatric Disorders in General Hospital Inpatients: A Systematic Umbrella Review.

Janeane L. Walker, N. Magill, M. Sharpe, 2022, Journal of the Academy of Consultation-Liaison Psychiatry.

Monitoring symptoms at home: what methods would cancer patients be comfortable using?

A. Kleiboer, Janeane L. Walker, M. Sharpe, 2010, Quality of Life Research.

ABC of psychological medicine

M. Sharpe, A. Carson, R. Mayou, 2003 .

for chronic illness ABC of psychological medicine: Organising care

R. Glasgow, M. Sharpe, M. Korff, 2006 .

Patients whom neurologists find difficult to help

C. Warlow, M. Sharpe, A. Carson, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

Integrating psychosocial care into cancer services.

M. Sharpe, J. Fann, K. Ell, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diagnosis, disease and illness.

M. Sharpe, R. Mayou, 1995, QJM : monthly journal of the Association of Physicians.

"Wheelchair" patients with nonorganic disease: a psychological inquiry.

D. Wade, M. Sharpe, C. Bass, 1999, Journal of psychosomatic research.

Conversion disorder: current problems and potential solutions for DSM-5.

W. LaFrance, D. Spiegel, M. Sharpe, 2011, Journal of psychosomatic research.

Treatment of depression in people with lung cancer: a systematic review.

Janeane L. Walker, M. Sharpe, G. Murray, 2013, Lung cancer.

The outcome of neurology outpatients with medically unexplained symptoms: a prospective cohort study

C. Warlow, M. Sharpe, A. Carson, 2003, Journal of neurology, neurosurgery, and psychiatry.

The outcome of depressive disorders in neurology patients: a prospective cohort study

C. Warlow, M. Sharpe, A. Carson, 2003, Journal of neurology, neurosurgery, and psychiatry.

Revising the classification of somatoform disorders: key questions and preliminary recommendations.

K. Kroenke, M. Sharpe, R. Sykes, 2007, Psychosomatics.

What is a psychological intervention? A metareview and practical proposal

A. Richardson, A. Kleiboer, Janeane L. Walker, 2011, Psycho-oncology.

Symptoms: a new approach

Janeane L. Walker, M. Sharpe, 2009 .

Bodily symptoms: a new approach

M. Sharpe, 2006 .

Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia)

A. Young, K. Hawton, M. Sharpe, 1998, Biological Psychiatry.

Title: Different independent associations of depression and anxiety with survival in patients with cancer Running head: Depression, anxiety and survival in patients with cancer

Janeane L. Walker, N. Magill, M. Sharpe, 2022 .

The interpretation of low mood and worry by high users of secondary care with medically unexplained symptoms

M. Sharpe, D. Weller, C. Burton, 2011, BMC family practice.

Patients repeatedly referred to secondary care with symptoms unexplained by organic disease: prevalence, characteristics and referral pattern.

G. Murray, M. Sharpe, D. Weller, 2010, Family practice.

Somatoform disorders in DSM-V.

M. Sharpe, J. Levenson, R. Mayou, 2003, Psychosomatics.

Risk factors for suicide in adults: systematic review and meta-analysis of psychological autopsy studies

S. Fazel, M. Sharpe, R. Yu, 2022, Evidence-Based Mental Health.

Misdiagnosis of conversion disorder.

M. Sharpe, M. Zeidler, J. Stone, 2003, The American journal of psychiatry.

Depression and anxiety in patients repeatedly referred to secondary care with medically unexplained symptoms: a case-control study

M. Sharpe, D. Weller, C. Burton, 2010, Psychological Medicine.

Frequent attenders without organic disease in a gastroenterology clinic. Patient characteristics and health care use.

M. Sharpe, C. Bass, A. Bond, 1999, General hospital psychiatry.

Uncritical positive regard? Issues in the efficacy and safety of psychotherapy

D. Nutt, M. Sharpe, 2008, Journal of psychopharmacology.

Screening medical patients for distress and depression: does measurement in the clinic prior to the consultation overestimate distress measured at home?

A. Kleiboer, M. Sharpe, G. Murray, 2013, Psychological Medicine.

Psychiatric Problems in the General Hospital

M. Sharpe, R. Mayou, 1991 .

Distress and concerns in couples referred to a specialist infertility clinic.

M. Sharpe, D. Irvine, A. Rattray, 2003, Journal of psychosomatic research.

A 1908 systematic review of the laterality of hysterical hemiplegia

C. Warlow, M. Sharpe, A. Carson, 2003, Journal of neurology, neurosurgery, and psychiatry.

Barriers to improving treatment

P. Henningsen, M. Sharpe, C. Fazekas, 2011 .

Edinburgh Research Explorer The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2): a randomised trial to determine the effectiveness and cost-effectiveness of adding a complex intervention for major depressive disorder to usual care for cancer patients

Janeane L. Walker, J. Cassidy, M. Sharpe, 2018 .

Better off dead: suicidal thoughts in cancer patients.

M. Fallon, Janeane L. Walker, M. Sharpe, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Functional symptoms in neurology: case studies.

M. Sharpe, J. Stone, 2006, Neurologic clinics.

Wayne Katon, MD (1950-2015). A leading academic consultation liaison psychiatrist and research pioneer whose work changed clinical practice

M. Sharpe, 2015 .

A survey of frequent attenders at a gastroenterology clinic.

M. Sharpe, C. Bass, A. Bond, 2001, Journal of psychosomatic research.

Treatment of functional somatic symptoms

C. Bass, M. Sharpe, R. Mayou, 1995 .

Patient reaction to the PACE trial - Authors' reply.

Anthony L. Johnson, T. Chalder, Janeane L. Walker, 2016, The lancet. Psychiatry.

Explorer The interpretation of low mood and worry by high users of secondary care with medically unexplained symptoms

M. Sharpe, D. Weller, C. Burton, 2017 .

Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics

C. Warlow, M. Sharpe, A. Carson, 2000, Journal of neurology, neurosurgery, and psychiatry.

Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcome

C. Warlow, K. Matthews, R. Cull, 2009, Psychological Medicine.

assessment and diagnosis Functional symptoms and signs in neurology

M. Sharpe, A. Carson, J. Stone, 2005 .

What do medical outpatients attending a neurology clinic think about antidepressants?

M. Sharpe, W. Wojcik, A. Carson, 2004, Journal of psychosomatic research.

Anorexia nervosa among female secondary school students in Ghana

M. Sharpe, A. Carson, C. Freeman, 2004, British Journal of Psychiatry.

Systemic Family Therapy in Adult Psychiatry a Review of 50 Families

S. Bloch, M. Sharpe, P. Allman, 1991, British Journal of Psychiatry.

Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial

G. Murray, Janeane L. Walker, M. Sharpe, 2014, The Lancet.

A history of liaison psychiatry in the UK

C. Bass, M. Sharpe, P. Aitken, 2016, BJPsych Bulletin.

A collaborative care approach delivering treatment to patients with depression comorbid with diabetes or cardiovascular disease achieves significant but small improvements over usual care in depression and patient satisfaction

M. Sharpe, 2015, Evidence-Based Mental Health.

Not all forms of collaborative care are the same

M. Sharpe, 2015, BMJ : British Medical Journal.

Motor conversion symptoms and pseudoseizures: a comparison of clinical characteristics.

M. Sharpe, J. Stone, M. Binzer, 2004, Psychosomatics.

Failure to Convulse with Electroconvulsive Therapy

M. Sharpe, B. Andrew, 1988, British Journal of Psychiatry.

Dualism Persists in the Science of Mind

Steven Laureys, M. Bruno, A. Zeman, 2009, Annals of the New York Academy of Sciences.

Is improvement in comorbid major depression associated with longer survival in people with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials.

Janeane L. Walker, M. Sharpe, C. Gourley, 2019, Journal of psychosomatic research.

The problems reported by cancer patients with major depression

A. Kleiboer, Janeane L. Walker, M. Sharpe, 2011, Psycho-oncology.

The psychological treatment of patients with functional somatic symptoms: a practical guide.

M. Sharpe, R. Mayou, R. Peveler, 1992, Journal of psychosomatic research.

Depression prevalence using the HADS-D compared to SCID major depression classification: An individual participant data meta-analysis.

Lorie A. Kloda, J. Ioannidis, P. Cuijpers, 2020, Journal of psychosomatic research.

Pathophysiological mechanisms in somatization

M. Sharpe, C. Bass, 1992 .

Psychological medicine and the future of psychiatry.

M. Sharpe, 2014, The British journal of psychiatry : the journal of mental science.

Prevention and Treatment of Suicidal Behaviour

S. Platt, M. Sharpe, F. O'May, 2005 .

Suicidal ideation among outpatients at general neurology clinics: prospective study

C. Warlow, Steven Best, M. Sharpe, 2000, BMJ : British Medical Journal.

Psychiatric comorbidity and risk of premature mortality and suicide among those with chronic respiratory diseases, cardiovascular diseases, and diabetes in Sweden: A nationwide matched cohort study of over 1 million patients and their unaffected siblings

P. Lichtenstein, H. Larsson, S. Fazel, 2022, PLoS medicine.

Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs

A. House, P. Maguire, M. Sharpe, 2004, British Journal of Cancer.

Treating medically unexplained physical symptoms

M. Sharpe, Richard Mayou, 1997, BMJ.

concern?schizophrenia in hostels for the homeless: a cause for

M. Sharpe, M. Marshall, 2012 .

Untreated schizophrenia in hostels for the homeless: a cause for concern?

M. Sharpe, M. Marshall, 1993 .

Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data.

Janeane L. Walker, M. Sharpe, G. Murray, 2014, The lancet. Psychiatry.

Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial.

T. Chalder, Janeane L. Walker, M. Sharpe, 2015, The lancet. Psychiatry.

Medically unexplained symptom management.

A. Schröder, P. Fink, M. Sharpe, 2015, The lancet. Psychiatry.

Cognitive-behavioural group treatment for a range of functional somatic syndromes: randomised trial.

A. Schröder, P. Fink, M. Sharpe, 2012, The British journal of psychiatry : the journal of mental science.

Helping to find the most accurate diagnosis

J. Dimsdale, M. Sharpe, F. Creed, 2013, BMJ : British Medical Journal.

Enhanced care by generalists for functional somatic symptoms and disorders in primary care.

P. Fink, R. Morriss, M. Sharpe, 2013, The Cochrane database of systematic reviews.

Long-term economic evaluation of cognitive-behavioural group treatment versus enhanced usual care for functional somatic syndromes.

A. Schröder, P. Fink, M. Sharpe, 2017, Journal of psychosomatic research.

Outcome measurement in functional somatic syndromes: SF-36 summary scores and some scales were not valid.

A. Schröder, P. Fink, M. Sharpe, 2012, Journal of clinical epidemiology.

Is there a better term than "medically unexplained symptoms"?

P. Henningsen, W. Rief, P. Fink, 2010, Journal of psychosomatic research.

What should we say to patients with symptoms unexplained by disease? The “number needed to offend”

Michael Sharpe, S. Lewis, C. Warlow, 2002, BMJ : British Medical Journal.

Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients.

Janeane L. Walker, M. Sharpe, G. Mchugh, 2007, Journal of psychosomatic research.

What do physicians think of somatoform disorders?

J. Dimsdale, M. Sharpe, N. Sharma, 2011, Psychosomatics.

Who is referred to neurology clinics?—The diagnoses made in 3781 new patients

C. Warlow, K. Matthews, R. Cull, 2010, Clinical Neurology and Neurosurgery.

Differing perspectives on diagnostic proposals for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.

J. Dimsdale, M. Sharpe, J. Levenson, 2011, Journal of psychosomatic research.

Systematic review of misdiagnosis of conversion symptoms and “hysteria”

Michael Sharpe, Roger Smyth, R. Prescott, 2005, BMJ : British Medical Journal.

24 – Psychiatry in general medical settings

Michael Sharpe, Janeane L. Walker, M. Sharpe, 2010 .

Unexplained Somatic Symptoms, Functional Syndromes, and Somatization: Do We Need a Paradigm Shift?

M. Sharpe, A. Carson, 2001, Annals of Internal Medicine.

Recent onset pseudoseizures—clues to aetiology

M. Sharpe, J. Stone, M. Binzer, 2004, Seizure.

The detection and management of emotional distress in cancer patients: the views of health‐care professionals

A. Richardson, M. Sharpe, G. Velikova, 2011, Psycho-oncology.

Prevalence of depression in adults with cancer: a systematic review.

Janeane L. Walker, M. Sharpe, G. Murray, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Major Depression and Survival in People With Cancer

Janeane L. Walker, N. Magill, M. Sharpe, 2021, Psychosomatic medicine.

Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7

M. Sharpe, G. Humphris, G. Ozakinci, 2018, Health and Quality of Life Outcomes.

Screening Medical Patients for Depression: Lessons From a National Program in Cancer Clinics.

Janeane L. Walker, M. Sharpe, Ariane Petit, 2017, Psychosomatics.

Emotion-Motion Interactions in Conversion Disorder: An fMRI Study

M. Reuber, P. Norman, M. Sharpe, 2014, Journal of Neurology, Neurosurgery & Psychiatry.

Functional weakness and sensory disturbance

A. Zeman, M. Sharpe, J. Stone, 2002, Journal of neurology, neurosurgery, and psychiatry.

Different independent associations of depression and anxiety with survival in patients with cancer.

Janeane L. Walker, N. Magill, M. Sharpe, 2020, Journal of psychosomatic research.

Cost-effectiveness of integrated collaborative care for comorbid major depression in patients with cancer☆

M Sculpher, M Sharpe, S. Walker, 2015, Journal of psychosomatic research.

The prevalence of depression in general hospital inpatients: a systematic review and meta-analysis of interview-based studies

Michael Sharpe, Stephen Puntis, Michelle Degli Esposti, 2018, Psychological Medicine.

Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials.

Janeane L. Walker, M. Sharpe, C. Gourley, 2018, The lancet. Psychiatry.

Title : Does depression treatment improve the survival of depressed cancer patients? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials.

Janeane L. Walker, M. Sharpe, C. Gourley, 2018 .

Treatment of depression in adults with cancer: a systematic review of randomized controlled trials

Janeane L. Walker, M. Sharpe, G. Murray, 2013, Psychological Medicine.

Screening for major depression in cancer outpatients

K. Kroenke, A. Kleiboer, Janeane L. Walker, 2011, Cancer.

Organising care for chronic illness

R. Glasgow, M. Von Korff, M. Sharpe, 2002, BMJ : British Medical Journal.

Somatic symptom disorder: an important change in DSM.

Sing Lee, M. Irwin, J. Dimsdale, 2013, Journal of psychosomatic research.

Somatoform disorders: A help or hindrance to good patient care?

M. Sharpe, R. Mayou, 2004, British Journal of Psychiatry.

fMRI in Patients With Motor Conversion Symptoms and Controls With Simulated Weakness

Enrico Simonotto, Martin Meyer, Michael Sharpe, 2007, Psychosomatic medicine.

Functional symptoms and signs in neurology: assessment and diagnosis

M Sharpe, M. Sharpe, A. Carson, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

The symptom of functional weakness: a controlled study of 107 patients.

Michael Sharpe, C. Warlow, M. Sharpe, 2010, Brain : a journal of neurology.

Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up?

C. Warlow, K. Matthews, R. Cull, 2009, Brain : a journal of neurology.

Somatoform disorders-new approaches to classification, conceptualization, and treatment.

W. Rief, M. Sharpe, 2004, Journal of psychosomatic research.

Music therapy in the setting of a psychotherapeutic centre.

M. Sharpe, G. Dickens, 1970, The British journal of medical psychology.

Attitudes of neuroscience nurses toward patients with conversion symptoms.

M. Sharpe, J. Stone, L. Ahern, 2009, Psychosomatics.

"Psychosomatic": a systematic review of its meaning in newspaper articles.

M. Sharpe, A. Carson, J. Stone, 2004, Psychosomatics.

Issues for DSM-5: Conversion disorder.

W. LaFrance, M. Sharpe, J. Levenson, 2010, The American journal of psychiatry.

Systematic review in conversion symptoms and hysteria: La belle indifférence

C. Warlow, M. Sharpe, A. Carson, 2011 .

Functional weakness and sensory disturbance

A. Zeman, M. Sharpe, J. Stone, 2002, Journal of neurology, neurosurgery, and psychiatry.

Which neurological diseases are most likely to be associated with “symptoms unexplained by organic disease”

C. Warlow, K. Matthews, R. Duncan, 2011, Journal of Neurology.

Eliot Slater's myth of the non-existence of hysteria.

C. Warlow, M. Sharpe, A. Carson, 2005, Journal of the Royal Society of Medicine.

Guided self-help for functional (psychogenic) symptoms

Janeane L. Walker, R. Duncan, I. Butcher, 2011, Neurology.

Are electronic diaries useful for symptoms research? A systematic review.

David Weller, Michael Sharpe, M. Sharpe, 2007, Journal of psychosomatic research.

Screening for suicidality in cancer patients using Item 9 of the nine-item patient health questionnaire; does the item score predict who requires further assessment?

K. Kroenke, A. Kleiboer, Janeane L. Walker, 2010, General hospital psychiatry.

Somatic symptom count scores do not identify patients with symptoms unexplained by disease: a prospective cohort study of neurology outpatients

K. Matthews, R. Duncan, M. Sharpe, 2014, Journal of Neurology, Neurosurgery & Psychiatry.

Sleep problems in cancer patients: prevalence and association with distress and pain

C. Espie, A. Kleiboer, Janeane L. Walker, 2012, Psycho-oncology.

The HOME Study: Statistical and economic analysis plan for a randomised controlled trial comparing the addition of Proactive Psychological Medicine to usual care, with usual care alone, on the time spent in hospital by older acute hospital inpatients

I. White, S. Walker, M. Sculpher, 2020, Trials.

Illness beliefs and locus of control: a comparison of patients with pseudoseizures and epilepsy.

M. Sharpe, J. Stone, M. Binzer, 2004, Journal of psychosomatic research.

Overview of epidemiology, classification, and aetiology

C. Bass, M. Sharpe, R. Mayou, 1995 .

Functional weakness: clues to mechanism from the nature of onset

C. Warlow, M. Sharpe, J. Stone, 2011, Journal of Neurology, Neurosurgery & Psychiatry.

Proactive Integrated Consultation-Liaison Psychiatry: A new service model for the psychiatric care of general hospital inpatients.

Janeane L. Walker, M. Sharpe, M. Toynbee, 2020, General hospital psychiatry.

Functional symptoms in neurology: management

M Sharpe, M. Sharpe, A. Carson, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Oncology professionals' views on the use of antidepressants in cancer patients: a qualitative interview study

A. Richardson, M. Sharpe, G. Velikova, 2011, BMJ Supportive & Palliative Care.

Psychological medicine: obstacles to delivery.

M. Sharpe, A. Carson, R. Mayou, 2004, Journal of psychosomatic research.

17 – Neurotic, stress-related and somatoform disorders

D. Baldwin, Janeane L. Walker, M. Sharpe, 2010 .

Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer.

Janeane L. Walker, M. Sharpe, C. Gourley, 2014, The Lancet. Oncology.

A primary care Symptoms Clinic for patients with medically unexplained symptoms: pilot randomised trial

M. Sharpe, W. Marsden, A. Worth, 2012, BMJ Open.

Implementing collaborative care programs for psychiatric disorders in medical settings: a practical guide.

S. Beach, Janeane L. Walker, C. Celano, 2015, General hospital psychiatry.

Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale - Depression subscale scores: An individual participant data meta-analysis of 73 primary studies.

Lorie A. Kloda, J. Ioannidis, Ying Sun, 2019, Journal of psychosomatic research.

Emotional outcomes after stroke: factors associated with poor outcome

C. Warlow, M. Dennis, M. Sharpe, 2000, Journal of neurology, neurosurgery, and psychiatry.

The report of the Chief Medical Officer's CFS/ME working group: what does it say and will it help?

M. Sharpe, 2002, Clinical medicine.

Concepts, theories, and terminology

C. Bass, M. Sharpe, R. Mayou, 1995 .

The psychological care of medical patients: Recognition of need and service provision - Royal-Coll-Physicians-Royal-Coll-Psych

M. Sharpe, 1996 .

Guided self-help for functional (psychogenic) symptoms A randomized controlled efficacy trial

I. Butcher, M. Sharpe, J. Cavanagh, 2011 .

Thoughts of death and suicide reported by cancer patients who endorsed the "suicidal thoughts" item of the PHQ-9 during routine screening for depression.

Janeane L. Walker, I. Butcher, M. Sharpe, 2011, Psychosomatics.

Integrated management of major depression for people with cancer

Janeane L. Walker, M. Sharpe, 2014, International review of psychiatry.

Psychosomatic medicine and evidence-based treatment.

M. Sharpe, R. Mayou, D. Gill, 1996, Journal of psychosomatic research.

Consultation-Liaison Psychiatry in the Outpatient Setting

Janeane L. Walker, M. Sharpe, 2007 .

The ‘disappearance’ of hysteria: Historical mystery or illusion?

Russell J. Hewett, C. Warlow, M. Sharpe, 2008, Journal of the Royal Society of Medicine.

Updates in Psychosomatic Medicine: 2014.

T. Stern, W. Söllner, S. Beach, 2015, Psychosomatics.

Implementing collaborative care for major depression in a cancer center: An observational study using mixed-methods.

A. Richardson, N. Sevdalis, Janeane L. Walker, 2022, General hospital psychiatry.

Personality change after stroke: some preliminary observations

M. Dennis, M. Sharpe, J. Kwan, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

Why do doctors find some patients difficult to help?

V. Seagroatt, M. Sharpe, C. Surawy, 1994, The Quarterly journal of medicine.

The effectiveness of inpatient consultation-liaison psychiatry service models: A systematic review of randomized trials.

Janeane L. Walker, M. Sharpe, E. Harriss, 2021, General hospital psychiatry.

The HOME Study: study protocol for a randomised controlled trial comparing the addition of Proactive Psychological Medicine to usual care, with usual care alone, on the time spent in hospital by older acute hospital inpatients

I. White, S. Walker, M. Sculpher, 2019, Trials.

Functional Somatic Symptoms and Psychological States: An Electronic Diary Study

David Weller, Michael Sharpe, M. Sharpe, 2009, Psychosomatic medicine.

Psychological autopsy studies of suicide: a systematic review

M. Sharpe, J. Cavanagh, A. Carson, 2003, Psychological Medicine.

Reduced complexity of activity patterns in patients with Chronic Fatigue Syndrome: a case control study

Michael Sharpe, Hans Knoop, Gijs Bleijenberg, 2009, BioPsychoSocial medicine.

The role of physical injury in motor and sensory conversion symptoms: a systematic and narrative review.

R. Prescott, C. Warlow, M. Sharpe, 2009, Journal of psychosomatic research.

Cost-effectiveness of combining systematic identification and treatment of co-morbid major depression for people with chronic diseases: the example of cancer

S. Walker, S. Palmer, M. Sculpher, 2013, Psychological Medicine.

Predisposing Risk Factors for Functional Limb Weakness: A Case-Control Study.

I. Deary, C. Warlow, M. Sharpe, 2019, The Journal of neuropsychiatry and clinical neurosciences.

A quantitative study of the emotional outcome of people caring for stroke survivors.

C. Warlow, M. Dennis, M. Sharpe, 1998, Stroke.

Measuring improvement in depression in cancer patients: a 50% drop on the self-rated SCL-20 compared with a diagnostic interview.

A. Kleiboer, Janeane L. Walker, I. Butcher, 2010, General hospital psychiatry.

Integration of mental and physical health care: from aspiration to practice.

C. Naylor, M. Sharpe, 2016, The lancet. Psychiatry.

Mood disorders in long-term survivors of stroke: associations with brain lesion location and volume

P. Sandercock, A. House, A. Molyneux, 1990, Psychological Medicine.

Knowledge, ignorance and priorities for research in key areas of cancer survivorship: findings from a scoping review

S. Brearley, A. Richardson, M. Sharpe, 2011, British Journal of Cancer.

A primary care Symptoms Clinic for patients with medically unexplained symptoms: pilot randomised trial

M. Sharpe, A. Worth, D. Weller, 2012, BMJ Open.

Differences in illness perceptions between patients with non-epileptic seizures and functional limb weakness.

M. Reuber, M. Sharpe, J. Stone, 2015, Journal of psychosomatic research.

Eliot Slater's myth of the Non-Existence of Hysteria

C. Warlow, M. Sharpe, A. Carson, 2005 .

The classification of conversion disorder (functional neurologic symptom disorder) in ICD and DSM.

M. Sharpe, J. Levenson, 2016, Handbook of clinical neurology.

Original Research Reports What Do Physicians Think of Somatoform Disorders

J. Dimsdale, M. Sharpe, N. Sharma, 2011 .

Ever since neurologist George Miller Beard coined the term neurasthenia in the 19th century

M. Sharpe, 2015 .

somatic syndromes: randomised trial behavioural group treatment for a range of functional - Cognitive

A. Schröder, P. Fink, M. Sharpe, 2012 .

Overcoming Functional Neurological Symptoms: A Five Areas Approach

M. Sharpe, J. Cavanagh, A. Carson, 2011 .

Bodily symptoms: new approaches to classification.

Janeane L. Walker, M. Sharpe, R. Mayou, 2006, Journal of psychosomatic research.

The HSCL-20: one questionnaire, two versions.

K. Kroenke, Janeane L. Walker, M. Sharpe, 2010, Journal of psychosomatic research.

Functional somatic syndromes: Etiology, diagnosis and treatment.

M. Sharpe, 2000 .

Risk of death by suicide following self-harm presentations to healthcare: development and validation of a multivariable clinical prediction rule (OxSATS)

P. Lichtenstein, B. D’Onofrio, Janeane L. Walker, 2023, BMJ Mental Health.

Depression Care for People with Cancer: a collaborative care intervention.

Janeane L. Walker, M. Sharpe, 2009, General hospital psychiatry.

Depression and anxiety during the year before death from cancer.

Janeane L. Walker, N. Magill, M. Sharpe, 2022, Journal of Psychosomatic Research.

Clinically relevant fatigue in cancer outpatients: the Edinburgh Cancer Centre symptom study.

M. Sharpe, M. Fallon, Janeane L. Walker, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

CANNABINOIDS AND hCG LEVELS IN PATIENTS WITH TESTICULAR CANCER

K. Sikora, M. Sharpe, H. Smedley, 1983, The Lancet.

Integrated management of major depression for people with cancer

Janeane L. Walker, M. Sharpe, 2014, International Review of Psychiatry.

Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial

G. Murray, Janeane L. Walker, M. Sharpe, 2014, The Lancet.

Linked symptom monitoring and depression treatment programmes for specialist cancer services: protocol for a mixed-methods implementation study

A. Richardson, N. Sevdalis, Janeane L. Walker, 2017, BMJ Open.

Selecting, training and supervising nurses to treat depression in the medically ill: experience and recommendations from the SMaRT oncology collaborative care trials.

A. Richardson, Janeane L. Walker, M. Sharpe, 2015, General hospital psychiatry.

The symptom of functional weakness: a controlled study of 107 patients.

C. Warlow, M. Sharpe, J. Stone, 2010, Brain : a journal of neurology.

Differences in relatives' and patients' illness perceptions in functional neurological symptom disorders compared with neurological diseases

M. Reuber, P. Norman, M. Sharpe, 2015, Epilepsy & Behavior.

Differences in illness perceptions between patients with non-epileptic seizures and functional limb weakness.

M. Reuber, M. Sharpe, J. Stone, 2015, Journal of psychosomatic research.

The initial development of an item bank to assess and screen for psychological distress in cancer patients

P. Selby, M. Sharpe, G. Velikova, 2007, Psycho-oncology.

Medical gaslighting: to say that invoking psychological symptoms is equivalent to dismissal is reductionist

M. Sharpe, 2022, BMJ.

The symptom of generalised fatigue

M. Sharpe, 2006, Practical Neurology.

Somatic symptoms: beyond ‘medically unexplained’

M. Sharpe, 2013, British Journal of Psychiatry.

Outcome measurement in functional somatic syndromes: SF-36 summary scores and some scales were not valid.

A. Schröder, P. Fink, M. Sharpe, 2012, Journal of clinical epidemiology.

Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up?

K. Matthews, R. Cull, Janeane L. Walker, 2009, Brain : a journal of neurology.

Amnesia for childhood in patients with unexplained neurological symptoms

M. Sharpe, J. Stone, G. Elrington, 2002, Journal of neurology, neurosurgery, and psychiatry.

The prevalence of anxiety in general hospital inpatients: A systematic review and meta-analysis.

Janeane L. Walker, N. Magill, Chris Frost, 2021, General hospital psychiatry.

CME: CLINICAL PRACTICE AND ITS BASIS

M. Sharpe, 2002 .

disability: they are related: a study of 300 consecutive new referrals to a neurology outpatient department

C. Warlow, M. Sharpe, A. Carson, 2022 .

Disability, distress and unemployment in neurology outpatients with symptoms ‘unexplained by organic disease’

K. Matthews, R. Duncan, M. Sharpe, 2011, Journal of Neurology, Neurosurgery & Psychiatry.